Our partner is an immunotherapy company developing multiple TAC-based therapeutic candidates using both autologous and allogeneic manufacturing approaches. All programs leveraging their TAC technology have the potential for broad applicability across cancers with a high unmet need.

This critical hire led early discovery and research efforts in the immunotherapy space. They were responsible for project management, including budgeting, timeline management, and monthly project report submissions. They were also responsible for managing vendor relationships.